carnitine has been researched along with dichloroacetic acid in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, W; Noell, C; Olson, MS; Scholz, R; Schwab, AJ; Schwabe, U | 1 |
| Brosnan, JT; Reid, K | 1 |
| Veerkamp, JH; Wirtz, P; Zuurveld, JG | 1 |
| Amir, N; Barash, V; De Vivo, DC; Elpeleg, ON; Jakobs, C; Ruitenbeek, W | 1 |
| Koch, HG; Kurlemann, G; Masur, H; Möller, H; Paetzke, I; Schuierer, G; Weglage, J | 1 |
| Constantin-Teodosiu, D; Greenhaff, PL; Macdonald, IA; Poucher, SM; Timmons, JA; Worrall, V | 1 |
| Patel, KP; Rozanski, GJ; Xu, Z | 1 |
| Kuroda, Y; Naito, E; Touda, Y | 1 |
| Hill, JA; Schofield, RS | 1 |
| Pauly, DF; Pepine, CJ | 1 |
| Celik, T; Iyisoy, A; Jata, B; Kursaklioglu, H | 1 |
| César, LA; Gowdak, LH; Mansur, AP | 1 |
| Bennett, N; Donohoe, DR; Han, A; Johnstone, M; MacDonald, A; Whelan, J | 1 |
| Heggermont, WA; Heymans, S; Papageorgiou, AP; van Bilsen, M | 1 |
5 review(s) available for carnitine and dichloroacetic acid
| Article | Year |
|---|---|
[Drug therapy for mitochondrial diseases].
Topics: Carnitine; Coenzymes; Cytochrome c Group; Cytochromes c; Dichloroacetic Acid; Drug Combinations; Drug Therapy, Combination; Flavin Mononucleotide; Humans; Mitochondrial Diseases; Succinic Acid; Thiamine; Thiamine Pyrophosphate; Ubiquinone | 2002 |
Role of metabolically active drugs in the management of ischemic heart disease.
Topics: Acetanilides; Animals; Cardiovascular Agents; Carnitine; Clinical Trials as Topic; Dichloroacetic Acid; Energy Metabolism; Fatty Acids; Glucose; Humans; Insulin; Myocardial Ischemia; Myocardium; Piperazines; Potassium; Ranolazine; Trimetazidine | 2001 |
Ischemic heart disease: metabolic approaches to management.
Topics: Acetanilides; Cardiovascular Agents; Carnitine; Dichloroacetic Acid; Energy Metabolism; Humans; Myocardial Ischemia; Oxidation-Reduction; Piperazines; Ranolazine; Ribose; Trimetazidine | 2004 |
The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
Topics: Acetanilides; Angina Pectoris; Animals; Carnitine; Clinical Trials as Topic; Coronary Artery Disease; Dichloroacetic Acid; Humans; Piperazines; Quality of Life; Ranolazine; Ribose; Surveys and Questionnaires; Trimetazidine; Vasodilator Agents | 2009 |
Metabolic support for the heart: complementary therapy for heart failure?
Topics: Acetyl-CoA C-Acyltransferase; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dichloroacetic Acid; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Glucose; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Perhexiline; Ranolazine; Stroke Volume; Trimetazidine | 2016 |
9 other study(ies) available for carnitine and dichloroacetic acid
| Article | Year |
|---|---|
The effect of fatty acids on the regulation of pyruvate dehydrogenase in perfused rat liver.
Topics: Acetoacetates; Animals; Caprylates; Carbon Dioxide; Carnitine; Dichloroacetic Acid; Fatty Acids; Hydroxybutyrates; Liver; Male; Oleic Acids; Oxygen Consumption; Pyruvate Dehydrogenase Complex; Pyruvates; Rats | 1978 |
Inhibition of palmitoylcarnitine oxidation by pyruvate in rat heart mitochondria.
Topics: Animals; Biological Transport; Carnitine; Coumaric Acids; Diabetes Mellitus, Experimental; Dichloroacetic Acid; In Vitro Techniques; Mitochondria, Heart; Oxidation-Reduction; Palmitoylcarnitine; Pyruvate Dehydrogenase Complex; Pyruvates; Rats; Uncoupling Agents | 1985 |
Skeletal muscle fibers in suspension: a new approach to the study of oxidative and glycolytic metabolism in differentiated muscle.
Topics: Animals; Carnitine; Cinnamates; Dichloroacetic Acid; Glucose; Glycolysis; In Vitro Techniques; Insulin; Lactates; Male; Microbial Collagenase; Monocarboxylic Acid Transporters; Muscles; Oxidation-Reduction; Palmitates; Palmitic Acids; Pyruvates; Rats; Rats, Inbred Strains | 1984 |
Congenital lacticacidemia caused by lipoamide dehydrogenase deficiency with favorable outcome.
Topics: Acidosis, Lactic; Carnitine; Dichloroacetic Acid; Dihydrolipoamide Dehydrogenase; Fibroblasts; Humans; Infant; Ketosis; Lactates; Male; Movement Disorders; Muscles; Thiamine | 1995 |
Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy.
Topics: Adolescent; Ascorbic Acid; Carnitine; Dichloroacetic Acid; Drug Therapy, Combination; Female; Humans; NAD(P)H Dehydrogenase (Quinone); Peripheral Nervous System Diseases; Riboflavin; Thiamine; Ubiquinone | 1995 |
Increased acetyl group availability enhances contractile function of canine skeletal muscle during ischemia.
Topics: Acetylcarnitine; Adenosine Triphosphate; Aerobiosis; Anaerobiosis; Animals; Carbohydrate Metabolism; Carnitine; Dichloroacetic Acid; Dogs; Electric Stimulation; Enzyme Activation; Female; In Vitro Techniques; Ischemia; Lactates; Lactic Acid; Muscle Contraction; Muscle, Skeletal; Peripheral Vascular Diseases; Pyruvate Dehydrogenase Complex | 1996 |
Metabolic basis of decreased transient outward K+ current in ventricular myocytes from diabetic rats.
Topics: Animals; Carnitine; Cells, Cultured; Diabetes Mellitus, Experimental; Dichloroacetic Acid; Electric Conductivity; Extracellular Space; Glucose; Hypoglycemic Agents; Insulin; Male; Myocardium; Osmolar Concentration; Potassium; Rats; Rats, Sprague-Dawley; Ventricular Function | 1996 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Carnitine; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Perhexiline; Trimetazidine; Vasodilator Agents; Vitamin B Complex | 2008 |
Cellular Metabolism and Dose Reveal Carnitine-Dependent and -Independent Mechanisms of Butyrate Oxidation in Colorectal Cancer Cells.
Topics: Acetylation; Antineoplastic Agents; Butyric Acid; Carnitine; Carnitine O-Palmitoyltransferase; Colorectal Neoplasms; Dichloroacetic Acid; Dose-Response Relationship, Drug; Energy Metabolism; HCT116 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Organic Cation Transport Proteins; Oxidation-Reduction; Phosphorylation; Pyruvate Dehydrogenase Complex; RNA Interference; Signal Transduction; Solute Carrier Family 22 Member 5; Time Factors; Transfection | 2016 |